HUMAN PF-4 |
人体重组型PF-4 |
37270-94-3 |
(13E,15S)-15-Hydroxy-9-oxoprosta-11,13-dien-1-oic acid |
(13E,15S)-15-Hydroxy-9-oxoprosta-11,13-dien-1-oic acid |
35687-86-6 |
SUBSTANCE P |
P物质 |
33507-63-0 |
ZINPYR-1 |
9-(2-羧基苯基)-2,7-二氯-4,5-双[二(2-吡啶基)氨基甲基]-6-羟基-3-黄原酮 |
288574-78-7 |
N-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]-2-furancarboxamide |
N-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]-2-furancarboxamide |
289494-16-2 |
Oxysterol 7-α-hydroxylase |
Oxysterol 7-α-hydroxylase |
288309-90-0 |
p33 protein kinase |
255064-79-0 |
255064-79-0 |
alefacept |
ALEFACEPT |
222535-22-0 |
ABH |
ABH |
222638-65-5 |
FLUORESCEIN DIPHOSPHATE, TETRAAMMONIUM SALT |
1, 6-二磷酸果糖钠 |
217305-49-2 |
ORFX |
ORFX |
1597439-89-8 |
BID |
人BH3结构域凋亡诱导蛋白(BID)ELISA试剂盒 |
1416258-16-6 |
ADAMTS 5 |
ADAMTS 5 |
1394122-20-3 |
HYMENISTATIN I |
HYMENISTATIN I |
1173938-18-5 |
Exodus-2, SLC |
Exodus-2, SLC |
182078-03-1 |
CEK11/FC CHIMERA |
EBK SALE6@WS-BIOLOGY.COM |
172306-57-9 |
HUMAN HCC-1 |
HUMAN HCC-1 |
169146-44-5 |
tuberous sclerosis 2 protein |
抗体:HUMAN TSC2 IP ANTIBODY (SAA0237) RHE71801 |
169027-60-5 |
(S)-2-Amino-2-methyl-4-phosphonobutanoic acid |
(S)-2-氨基-2-甲基-4-磷酰丁酸 |
157381-42-5 |
2,2'-BIS(DI-P-TOLYLPHOSPHINO)-1,1'-BINAPHTHYL |
(±)-2,2 '-二(二-对甲苯基膦)-1,1 '-联萘 |
153305-67-0 |